|
|
 |
|
| PDB id |
|
Count |
|
Name |
|
Method |
|
Date |
|
|
|
|
×0
|
|
Structure of the hirulog 3-thrombin complex and nature of the s' subsites of substrates and inhibitors
|
|
X-ray(2.3Å)
|
|
31-Jan-94
|
|
|
|
×0
|
|
Dithiol alpha melanotropin peptide cyclized via rhenium metal coordination
|
|
NMR(1 model)
|
|
18-Nov-98
|
|
|
|
×0
|
|
Retro-inverso analogue of the g-h loop of vp1 in foot-and-mouth- disease (fmd) virus, nmr, 10 structures
|
|
NMR(10 models)
|
|
13-Jan-99
|
|
|
|
×0
|
|
Monitoring the structural consequences of phe12-->d-phe12 and leu15-- >aib15 substitution in h/r corticotropin releasing hormone: implications for design of crh antagonists.
|
|
NMR(1 model)
|
|
31-Oct-01
|
|
|
|
×0
|
|
Monitoring the structural consequences of phe12-->d-phe12 and leu15-- >aib15 substitution in h/r corticotropin releasing hormone: implications for design of crh antagonists.
|
|
NMR(40 models)
|
|
31-Oct-01
|
|
|
|
×0
|
|
Crystal structure of the complex of human alpha-thrombin and non- hydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6
|
|
X-ray(2Å)
|
|
31-Jan-94
|
|
|
|
×0
|
|
Crystal structure of the complex of human alpha-thrombin and non- hydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6
|
|
X-ray(2.1Å)
|
|
31-Jan-94
|
|
|
|
×0
|
|
Principles and pitfalls in designing site directed peptide ligands
|
|
X-ray(2.7Å)
|
|
31-Jan-94
|
|
|
|
×0
|
|
Principles and pitfalls in designing site directed peptide ligands
|
|
X-ray(2.7Å)
|
|
31-Jan-94
|
|
|
|
×0
|
|
Principles and pitfalls in designing site directed peptide ligands
|
|
X-ray(Å)
|
|
31-Jan-94
|
|
|
|
×0
|
|
Principles and pitfalls in designing site directed peptide ligands
|
|
X-ray(2.7Å)
|
|
31-Jan-94
|
|
|
|
×0
|
|
Principles and pitfalls in designing site directed peptide ligands
|
|
X-ray(2.7Å)
|
|
31-Jan-94
|
|
|
|
×0
|
|
Principles and pitfalls in designing site directed peptide ligands
|
|
X-ray(2.7Å)
|
|
31-Jan-94
|
|
|
|
×0
|
|
Principles and pitfalls in designing site directed peptide ligands
|
|
X-ray(2.7Å)
|
|
31-Jan-94
|
|
|
|
×0
|
|
Principles and pitfalls in designing site directed peptide ligands
|
|
X-ray(2.7Å)
|
|
31-Jan-94
|
|
|
|
×0
|
|
Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes
|
|
X-ray(3.5Å)
|
|
31-May-94
|
|
|
|
×0
|
|
Structure of subtilisin a
|
|
NMR(8 models)
|
|
22-Jun-04
|
|
|
|
×1
|
|
Crystal structure of the complex between thrombin and the central "e" region of fibrin
|
|
X-ray(3.65Å)
|
|
02-Mar-04
|
|
|
|
×0
|
|
Nmr study of the backbone conformational equilibria of sandostatin, minimized average beta-sheet structure
|
|
NMR(1 model)
|
|
21-Apr-97
|
|
|
|
×0
|
|
Crystal structure of the complex formed between alkaline proteinase savinase and gramicidin s at 1.5a resolution
|
|
X-ray(1.54Å)
|
|
22-Jun-04
|
|
|
|
×1
|
|
Streptomyces griseus aminopeptidase complexed with d-phenylalanine
|
|
X-ray(1.25Å)
|
|
14-Jun-05
|
|
|
|
×0
|
|
Molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide cyclotheonamide a
|
|
X-ray(2.3Å)
|
|
31-Jan-94
|
|
|
|
×0
|
|
Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms
|
|
X-ray(2.2Å)
|
|
30-Sep-94
|
|
|
|
×0
|
|
3d solution structure of [tyr3]octreotate derivatives in dmso
|
|
NMR(21 models)
|
|
20-Sep-05
|
|
|
|
×0
|
|
3d solution structure of [tyr3]octreotate derivatives in dmso
|
|
NMR(21 models)
|
|
20-Sep-05
|
|
|
|
×5
|
|
The crystal structure of d-amino acid amidase from ochrobactrum anthropi sv3 complexed with d-phenylalanine
|
|
X-ray(2.4Å)
|
|
07-Feb-06
|
|
|
|
×4
|
|
The crystal structure of d-amino acid amidase from ochrobactrum anthropi sv3 complexed with d-phenylalanine
|
|
X-ray(2.4Å)
|
|
09-May-06
|
|
|
|
×0
|
|
Carbonic anhydrase activators. Activation of isoforms i, ii, iv, va, vii and xiv with l- and d- phenylalanine, structure with d- phenylalanine.
|
|
X-ray(1.6Å)
|
|
23-May-06
|
|
|
|
×0
|
|
Structure of the hirugen and hirulog 1 complexes of alpha-thrombin
|
|
X-ray(2.2Å)
|
|
31-Jan-94
|
|
|
|
×0
|
|
Model of melanocortin-4 receptor with agonist ndpmsh
|
|
Theor. model
|
|
24-Oct-06
|
|
|
|
×0
|
|
Solution structure of a novel d-amino acid containing conopeptide, conomarphin at ph 5
|
|
NMR(20 models)
|
|
03-Jun-08
|
|
|
|
×0
|
|
Structure and sodium channel activity of an excitatory i1-superfamily conotoxin
|
|
NMR(20 models)
|
|
23-Oct-07
|
|
|
|
×0
|
|
Trithiol alpha melanocyte stimulating hormone cyclized through rhenium coordination
|
|
Theor. model
|
|
30-Sep-98
|
|
|
|
×0
|
|
Nmr structure of peptide pg-989 in dpc micelles
|
|
NMR(10 models)
|
|
16-Dec-15
|
|
|
|
×3
|
|
Crystal structure of all-d monellin at 1.8 a resolution
|
|
X-ray(1.8Å)
|
|
13-Nov-07
|
|
|
|
×0
|
|
Crystal structure of the d10-p3/iqn17 complex: a d-peptide inhibitor of HIV-1 entry bound to the gp41 coiled-coil pocket
|
|
X-ray(1.5Å)
|
|
12-Jun-07
|
|
|
|
×0
|
|
Astressin2b
|
|
NMR(20 models)
|
|
01-Jan-08
|
|
|
|
×0
|
|
Astressin-b
|
|
NMR(20 models)
|
|
01-Jan-08
|
|
|
|
×0
|
|
Stressin
|
|
NMR(20 models)
|
|
01-Jan-08
|
|
|
|
×0
|
|
3d nmr structure of astressin
|
|
NMR(20 models)
|
|
30-Oct-07
|
|
|
|
×0
|
|
Nmr study of the backbone conformational equilibria of sandostatin, two representative minimum energy partially helical structures
|
|
NMR(2 models)
|
|
21-Apr-97
|
|
|
|
×0
|
|
Factor ixa superactive triple mutant
|
|
X-ray(1.5Å)
|
|
22-Dec-09
|
|
|
|
×0
|
|
Factor ixa superactive double mutant
|
|
X-ray(1.99Å)
|
|
22-Dec-09
|
|
|
|
×0
|
|
Factor ixa superactive triple mutant, nacl-soaked
|
|
X-ray(1.6Å)
|
|
22-Dec-09
|
|
|
|
×0
|
|
Factor ixa superactive triple mutant, ethylene glycol-soaked
|
|
X-ray(2.21Å)
|
|
22-Dec-09
|
|
|
|
×0
|
|
Factor ixa superactive triple mutant, edta-soaked
|
|
X-ray(1.82Å)
|
|
22-Dec-09
|
|
|
|
×2
|
|
Foldon containing d-amino acids in turn positions
|
|
X-ray(0.98Å)
|
|
29-Sep-10
|
|
|
|
×0
|
|
Purification and structural characterization of a d-amino acid containing conopeptide, marmophine, from conus marmoreus
|
|
NMR(20 models)
|
|
08-Apr-08
|
|
|
|
×0
|
|
The x-ray structure of human prostasin in complex with dffr- chloromethyl ketone inhibitor
|
|
X-ray(1.7Å)
|
|
16-Jun-09
|
|
|
|
×1
|
|
Crystal structure of d-enantiomer of human alpha-defensin 1 (d-hnp1)
|
|
X-ray(1.56Å)
|
|
28-Jul-09
|
|
|
|
×1
|
|
Crystal structure of human mdm2 complexed with d-peptide (12 residues)
|
|
X-ray(1.93Å)
|
|
21-Apr-10
|
|
|
|
×3
|
|
D-peptide inhibitor pie71 in complex with iqn17
|
|
X-ray(1.4Å)
|
|
02-Mar-11
|
|
|
|
×0
|
|
Crystal structure of quasiracemic villin headpiece subdomain containing (f5phe10) substitution
|
|
X-ray(1.46Å)
|
|
25-Jan-12
|
|
|
|
×0
|
|
Crystal structure of quasiracemic villin headpiece subdomain containing (f5phe17) substitution
|
|
X-ray(1Å)
|
|
25-Jan-12
|
|
|
|
×0
|
|
Crystal structure of racemic villin headpiece subdomain in space group i-4c2
|
|
X-ray(2.3Å)
|
|
25-Jan-12
|
|
|
|
×0
|
|
Human thrombin complexed with d-phe-pro-d-arg-d-thr
|
|
X-ray(1.28Å)
|
|
23-May-12
|
|
|
|
×0
|
|
Human thrombin complexed with d-phe-pro-d-arg-ile
|
|
X-ray(1.47Å)
|
|
23-May-12
|
|
|
|
×0
|
|
Human thrombin complexed with d-phe-pro-d-arg-cys
|
|
X-ray(1.86Å)
|
|
11-Apr-12
|
|
|
|
×0
|
|
X-ray crystal structure of a novel topological analogue of crambin
|
|
X-ray(1.08Å)
|
|
08-Feb-12
|
|
|
|
×0
|
|
Crystal structure of mate in complex with mad5
|
|
X-ray(3Å)
|
|
03-Apr-13
|
|
|
|
×0
|
|
Crystal structure of mate in complex with mad3s
|
|
X-ray(2.6Å)
|
|
03-Apr-13
|
|
|
|
×0
|
|
Human alpha-thrombin-bivalirudin complex at pd5.0
|
|
X-ray(1.25Å)
|
|
04-Sep-13
|
|
|
|
×0
|
|
X/n joint refinement of human alpha-thrombin-bivalirudin complex pd5
|
|
X-ray(1.6Å)
|
|
04-Sep-13
|
|
|
|
×7
|
|
Crystal structure of chemically synthesized heterochiral {d-protein antagonist plus vegf-a} protein complex in space group p21/n
|
|
X-ray(1.6Å)
|
|
05-Sep-12
|
|
|
|
×18
|
|
Crystal structure of chemically synthesized heterochiral {d-protein antagonist plus vegf-a} protein complex in space group p21
|
|
X-ray(1.6Å)
|
|
05-Sep-12
|
|
|
|
×20
|
|
Crystal structure of the mirror image form of vegf-a
|
|
X-ray(1.9Å)
|
|
05-Sep-12
|
|
|
|
×0
|
|
Structure of the ternary complex of bacitracin, zinc, and geranyl- pyrophosphate
|
|
X-ray(1.1Å)
|
|
14-Aug-13
|
|
|
|
×0
|
|
Crystal structure of the catalytic domain of botulinum neurotoxin bont/a c134s mutant with covalent inhibitor that modifies cys-165 causing disorder in 166-174 stretch
|
|
X-ray(1.93Å)
|
|
25-Jun-14
|
|
|
|
×0
|
|
The high resolution structure of tyrocidine a reveals an amphipathic dimer
|
|
X-ray(0.95Å)
|
|
19-Mar-14
|
|
|
|
×4
|
|
X-ray crystal structure of racemic non-glycosylated chemokine ser-ccl1
|
|
X-ray(2Å)
|
|
07-May-14
|
|
|
|
×4
|
|
(Quasi-)racemic x-ray crystal structure of glycosylated chemokine ser- ccl1.
|
|
X-ray(2.1Å)
|
|
07-May-14
|
|
|
|
×0
|
|
Racemic structure of sunflower trypsin inhibitor-1 (sfti-1)
|
|
X-ray(1.25Å)
|
|
10-Sep-14
|
|
|
|
×1
|
|
Yeast 20s proteasome beta5-g48c mutant in complex with alpha- chloroacetamide 5
|
|
X-ray(2.5Å)
|
|
02-Dec-15
|
|
|
|
×9
|
|
Structure of quasiracemic ala-magainin 2 with a beta amino acid substitution at position 8
|
|
X-ray(2.2Å)
|
|
23-Sep-15
|
|
|
|
×3
|
|
Structure of quasiracemic ala-magainin 2 with a beta amino acid substitution at position 13
|
|
X-ray(1.5Å)
|
|
23-Sep-15
|
|
|
|
×1
|
|
3-deoxy-d-arabino-heptulosonate 7-phosphate synthase from mycobacterium tuberculosis in complex with d-phenylalanine
|
|
X-ray(2.5Å)
|
|
01-Jun-16
|
|
|
|
×1
|
|
Quasi-racemic snakin-1 in p1 after radiation damage
|
|
X-ray(1.57Å)
|
|
18-May-16
|
|
|
|
×1
|
|
Quasi-racemic snakin-1 in p1 before radiation damage
|
|
X-ray(1.51Å)
|
|
18-May-16
|
|
|
|
×1
|
|
3-deoxy-d-arabino-heptulosonate 7-phosphate synthase from mycobacterium tuberculosis in complex with d/l-tryptophan and d- phenylalanine
|
|
X-ray(2.4Å)
|
|
01-Jun-16
|
|
|
|
×0
|
|
Linear tri-ubiquitin
|
|
X-ray(1.8Å)
|
|
02-Nov-16
|
|
|
|
×0
|
|
Linear tetra-ubiquitin
|
|
X-ray(2.21Å)
|
|
02-Nov-16
|
|
|
|
×0
|
|
Lys6-linked di-ubiquitin
|
|
X-ray(1.15Å)
|
|
02-Nov-16
|
|
|
|
×0
|
|
Lys11-linked diubiquitin
|
|
X-ray(1.73Å)
|
|
02-Nov-16
|
|
|
|
×2
|
|
Lys27-linked di-ubiquitin
|
|
X-ray(1.15Å)
|
|
02-Nov-16
|
|
|
|
×0
|
|
Lys29-linked di-ubiquitin
|
|
X-ray(1.98Å)
|
|
02-Nov-16
|
|
|
|
×0
|
|
Lys33-linked di-ubiquitin
|
|
X-ray(1.95Å)
|
|
02-Nov-16
|
|
|
|
×2
|
|
Lys48-linked di-ubiquitin
|
|
X-ray(1.59Å)
|
|
02-Nov-16
|
|
|
|
×0
|
|
Lys63-linked di-ubiquitin
|
|
X-ray(1.55Å)
|
|
02-Nov-16
|
|
|
|
×0
|
|
K11/k63-branched tri-ubiquitin
|
|
X-ray(1.84Å)
|
|
02-Nov-16
|
|
|
|
×7
|
|
Crystal structure of chemically synthesized heterochiral {rfx037 plus vegf-a} protein complex in space group p21/n
|
|
X-ray(2.1Å)
|
|
09-Mar-16
|
|
|
|
×15
|
|
Crystal structure of chemically synthesized heterochiral {rfx037 plus vegf-a} protein complex in space group p21
|
|
X-ray(2.1Å)
|
|
09-Mar-16
|
|
|
|
×12
|
|
Villin headpiece subdomain with a gln26 to beta-3-homoglutamine substitution
|
|
X-ray(1.3Å)
|
|
25-May-16
|
|
|
|
×10
|
|
Villin headpiece subdomain with a gln26 to acpc substitution
|
|
X-ray(1.35Å)
|
|
25-May-16
|
|
|
|
×12
|
|
Villin headpiece subdomain with a lys30 to beta-3-homolysine substitution
|
|
X-ray(1.4Å)
|
|
25-May-16
|
|
|
|
×4
|
|
Villin headpiece subdomain with a lys30 to apc substitution
|
|
X-ray(1.12Å)
|
|
25-May-16
|
|
|
|
×0
|
|
Quasi racemic structure of allo-ile7-shk and d-shk
|
|
X-ray(1.2Å)
|
|
25-Jan-17
|
|
|
|
×0
|
|
Quasi racemic structure of allo-thr13-shk and d-shk
|
|
X-ray(0.9Å)
|
|
25-Jan-17
|
|
|
|
×0
|
|
Lys27-linked diubiquitin
|
|
X-ray(1.55Å)
|
|
18-May-16
|
|
|
|
×0
|
|
Lys27-linked triubiquitin
|
|
X-ray(2.1Å)
|
|
18-May-16
|
|
|
|
×4
|
|
Lys27-linked triubiquitin
|
|
X-ray(1.99Å)
|
|
20-Jul-16
|
|
